Oncolytic Virus Therapy Market Revenue 2024 to 2034
Oncolytic Virus Therapy Market Revenue 2024 to 2034
The Oncolytic Virus Therapy Market is projected to grow from USD 3.44 Bn in 2024 to USD 11.92 Bn by 2034, expanding at a CAGR of 13.2%.
Report ID: 10296
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 3.44 Bn
Forecast Year,
USD USD 11.92 Bn
CAGR, 2025 -
13.2%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Oncolytic Virus Therapy Market Size Analysis
Oncolytic Virus Therapy Market Size By Virus Type 2024 to 2034 (USD )
| Virus Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Adenovirus | 1.03 | 1.17 | 1.32 | 1.50 | 1.70 | 1.92 | 2.16 | 2.45 | 2.76 | 3.13 | 3.56 |
| HSV | 0.76 | 0.86 | 0.97 | 1.09 | 1.24 | 1.40 | 1.60 | 1.80 | 2.05 | 2.31 | 2.60 |
| Vaccinia | 0.55 | 0.62 | 0.71 | 0.80 | 0.91 | 1.03 | 1.16 | 1.32 | 1.49 | 1.70 | 1.93 |
| Reovirus | 0.41 | 0.47 | 0.53 | 0.60 | 0.68 | 0.77 | 0.87 | 0.99 | 1.12 | 1.27 | 1.44 |
| Others | 0.69 | 0.78 | 0.88 | 1.00 | 1.13 | 1.28 | 1.46 | 1.65 | 1.88 | 2.11 | 2.40 |
Oncolytic Virus Therapy Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Melanoma | 0.76 | 0.85 | 0.97 | 1.10 | 1.24 | 1.40 | 1.58 | 1.79 | 2.04 | 2.31 | 2.62 |
| Head & Neck | 0.55 | 0.63 | 0.71 | 0.81 | 0.91 | 1.04 | 1.18 | 1.33 | 1.52 | 1.72 | 1.95 |
| Glioma | 0.41 | 0.46 | 0.53 | 0.60 | 0.68 | 0.77 | 0.88 | 0.99 | 1.12 | 1.26 | 1.42 |
| Liver | 0.34 | 0.39 | 0.44 | 0.50 | 0.57 | 0.64 | 0.73 | 0.83 | 0.94 | 1.05 | 1.19 |
| Others | 1.37 | 1.55 | 1.76 | 1.99 | 2.25 | 2.55 | 2.88 | 3.26 | 3.68 | 4.19 | 4.73 |
Oncolytic Virus Therapy Market Size By Route 2024 to 2034 (USD )
| Route | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Intratumoral | 2.27 | 2.57 | 2.91 | 3.30 | 3.74 | 4.24 | 4.81 | 5.43 | 6.17 | 7.00 | 7.94 |
| Systemic/IV | 1.17 | 1.32 | 1.50 | 1.69 | 1.91 | 2.16 | 2.44 | 2.77 | 3.12 | 3.53 | 3.98 |
Oncolytic Virus Therapy Market Size By End-User 2024 to 2034 (USD )
| End-User | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 1.65 | 1.86 | 2.11 | 2.39 | 2.70 | 3.07 | 3.47 | 3.92 | 4.43 | 5.01 | 5.69 |
| Cancer Centers | 1.10 | 1.25 | 1.42 | 1.60 | 1.81 | 2.05 | 2.33 | 2.65 | 3.01 | 3.40 | 3.86 |
| Others | 0.69 | 0.78 | 0.88 | 1.00 | 1.14 | 1.29 | 1.45 | 1.64 | 1.85 | 2.11 | 2.38 |
Oncolytic Virus Therapy Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.58 | 1.79 | 2.04 | 2.31 | 2.60 | 2.95 | 3.33 | 3.80 | 4.32 | 4.88 | 5.52 |
| Europe | 1.03 | 1.16 | 1.31 | 1.49 | 1.69 | 1.91 | 2.17 | 2.43 | 2.76 | 3.13 | 3.55 |
| Asia Pacific | 0.62 | 0.70 | 0.79 | 0.90 | 1.02 | 1.16 | 1.31 | 1.49 | 1.68 | 1.89 | 2.15 |
| Latin America | 0.10 | 0.12 | 0.13 | 0.15 | 0.17 | 0.19 | 0.22 | 0.24 | 0.27 | 0.31 | 0.35 |
| Middle East & Africa | 0.10 | 0.12 | 0.13 | 0.15 | 0.17 | 0.19 | 0.22 | 0.24 | 0.28 | 0.31 | 0.35 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
